Navigation Links
InspireMD Announces First Quarter 2012 Financial Results
Date:5/8/2012

2; stent provides outstanding and lifelong embolic protection, without affecting deliverability. MGuard™ is CE Mark approved. Mesh-based protection is now recommended for use in the recent Guidelines of the Task force of Myocardial Revascularization of the European Society of Cardiology (ESC).

MGuard™ is currently being investigated in the multi-center international MASTER (MGuard™ for Acute ST Elevation Reperfusion) trial. This study has been designed to evaluate the MGuard™ stent compared to commercially-approved BMS or DES products in STEMI patients undergoing primary angioplasty. Preliminary top line results are expected in the third quarter of 2012. Plans for a registration study in the US are also at an advanced stage.

About InspireMD, Inc.InspireMD is a medical device company focused on the development and commercialization of its proprietary stent system technology, MGuard. InspireMD intends to pursue applications of this technology in coronary, carotid and peripheral artery procedures. InspireMD's common stock is listed on the OTC BB under the ticker symbol "NSPR".

Forward-looking Statements: This press release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative c
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
2. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
3. InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
4. InspireMD Boosts MGuard Production Capacity
5. InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR"
6. InspireMD to Participate in Benchmark Company, LLC 2011 One-On-One Investor Conference
7. InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India
8. InspireMD Promotes MGuard™ at the EuroPCR 2011 Exhibition and Conference in Paris This Week
9. InspireMD Announces Year-to-Date 2011 Progress
10. InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation
11. Sol J. Barer, Ph.D. Joins InspireMD Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015 E-QURE Corp (OTCQB: EQUR), ... live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
(Date:7/6/2015)... -- Celtaxsys, Inc., a clinical stage pharmaceutical development company ... orphan inflammatory disease indications, announced today that it has ... (FDA) to begin a Phase 2 clinical trial of ... patients in the US. The regulatory submissions to the ... be filed soon after. This groundbreaking clinical study, testing ...
(Date:7/6/2015)... , July 6, 2015  OncoSec Medical Inc. ... intratumoral cancer immunotherapies, today announced the appointment of ... of Vice President of Market Development, effective July 6, ... for evaluating, designing, and executing on the company,s market ... "I,m very excited to welcome Joann to the ...
Breaking Medicine Technology:E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 2OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 3
(Date:7/6/2015)... ... July 06, 2015 , ... Olive Fertility Centre is ... 2014-2015 Post Graduate Teaching Award on behalf of the department of Family Practice. , ... exciting field to be practicing in. The technology is changing so rapidly and we ...
(Date:7/6/2015)... ... July 06, 2015 , ... Longevity, ... has partnered with Woodbridge Walk-In Urgent Care to offer on-site health screenings. These ... medical conditions. Screenings are affordable and accurate and run about an hour long ...
(Date:7/6/2015)... ... July 06, 2015 , ... Health care systems and genomics projects have generated ... to access and use this “Big Data” to improve health and cut costs is ... of the Mount Sinai Health System in New York City. Physicians will have these ...
(Date:7/6/2015)... ... July 06, 2015 , ... In a split second, breaking a ... their risk of having a fracture through the bone health screenings conducted by American ... “We are participating because our residents need this information to remain independent and strong ...
(Date:7/6/2015)... ... July 06, 2015 , ... World renowned Los ... to achieve their ideal appearance through comprehensive treatment solutions. Individuals that want to make ... doctor and receive a plan that resolves each of their needs. , "Anytime ...
Breaking Medicine News(10 mins):Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:National Bone Health Screening and Awareness Day 2Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2
... 11 They feature real patients, real stories and ... campaign titled "Real Patients, Real Stories" won Platinum in ... event held in Chicago this fall. , Baylor teamed ... the non-traditional spots. The documentary-style ads feature actual patients ...
... 41.9% with the greatest reduction in child casualties, according to ... Road traffic injuries are a leading cause of death ... important contribution to public health burdens over the coming decades, ... UK has a comparatively good road injury record, with among ...
... cells can lose their epithelial receptors, a process that enables ... from The University of Texas M. D. Anderson Cancer Center. ... Antonio Breast Cancer Symposium. Levels of these circulating tumor ... or its metastases - have been used to monitor and ...
... that could prevent another blood clot, study finds , FRIDAY, ... survivors don,t take medications that can reduce their risk of ... is caused by blocked blood flow in the brain. Several ... stroke. These include blood thinners (antithrombotic medications), of which aspirin ...
... , , , GAINESVILLE, Fla., Dec. ... studied the amazing regenerative power of salamanders, trying to ... usually leave humans and other mammals paralyzed -- or ... Institutes of Health Grand Opportunity grant of $2.4 million, ...
... , PHILADELPHIA, Dec. 11 Autism research ... one of the top ten medical breakthroughs of 2009 by Time ... Time cited the largest-ever genetic study of autism spectrum disorders (ASDs), ... led by Hakon Hakonarson, M.D., Ph.D., director of the Center for Applied ...
Cached Medicine News:Health News:Baylor Health Care System's Patient Testimonial Ad Campaign Wins National Award 2Health News:More 20 mph zones in London would prevent 100 killed or seriously injured casualties each year 2Health News:Novel detection method unmasks circulating breast cancer cells 2Health News:Novel detection method unmasks circulating breast cancer cells 3Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 2Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 3Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 4Health News:Autism Research at the Children's Hospital of Philadelphia Is Among Time Magazine's Top 10 Medical Breakthroughs 2
... Portable Slit-Lamp. Rechargeable, cordless ... for any purpose , Easy selection ... blue filter , Extra-bright halogen lamp ... main and extra ,power pack , ...
The PillCam™ ESO video capsule is specifically designed to view the inner lining of the Esophagus. The capsule is equipped with miniature cameras on both ends and is about the size of a multi-v...
World's first commercially available vacuum assisted biopsy device for MRI....
... Now you can perform stereotactic, ultrasound ... the convenience of your office. Use the ... safer, easier and more clinically advanced method ... its best for the women who trust ...
Medicine Products: